Multiple drug resistance of Vibrio cholerae O1 and O139 isolated from various regions of the world: Changes in the past 10 years

Acta Medica et Biologica

Volumn 48, Issue 3, 2000, Pages 75-88

  Yamamoto, T ^a   Taneike, I ^a   Tamura, Y ^a   Wakisaka Saito, N ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Multiple drug resistance; R plasmid; VC MAR pattern; Vibrio cholerae O1; Vibrio cholerae O139

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; NALIDIXIC ACID; NORFLOXACIN; QUINOLONE; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CHOLERA; CHROMOSOME; DRUG SENSITIVITY; HUMAN; MULTIDRUG RESISTANCE; PLASMID; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

EID: 0034532098     PISSN: 05677734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Cholera
2. Cholera during last hundred years (1884-1983)
3. World Health Organization: Cholera in the Americas
4. Cholera in 1991
5. Large outbreak of clinical cholera due to Vibrio cholerae non-O 1 in Bangladesh
6. Vibrio cholerae O 139 Bengal in Bangkok
7. Committee on epidemic diseases: Cholera
8. Vibrio cholerae O139 in Karachi, Pakistan
9. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India
10. Epidemic diarrhoea due to Vibrio cholerae non-O 1
11. Non-O 1 Vibrio cholerae
12. Cholera in 1994. Part I
13. Comment on Ciprofloxacin for Cholera
14. Multiple antibiotic resistant strain of El Tor Vibrio isolated in the Philippines
15. Survey of in vitro susceptibilities of Vibrio cholerae O 1 and O139 to antimicrobial agents
16. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O 139
17. Isolation and identification of Vibrio cholerae O1 from Fecal Specimens
18. Pathogenesis of experimental cholera: Preparation and isolation of choleragen and choleragenoid
19. Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against gramnegative organisms
20. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates
21. Japan Society of Chemotherapy: Committee report
22. Japan Society of Chemotherapy: Committee report: Methods of sensitivity testing for sulfamethoxazoletrimethoprim combination product
23. Rapid procedure for detection and isolation of large and small plasmids
24. Genetic and physical map of plasmid NR1: Comparison with other IncFII antibiotic resistance plasmids
25. Conjugative transfer of R·plasmids from Streptococcus faecalis to Staphylococcus aureus
26. DNA Insertion Elements, Plasmids, and Episomes
27. R plasmids from Asian strains of Vibrio cholerae
28. Oral rehydration therapy (ORT): Present and future
29. Cholera: Pathophysiology, clinical features, and treatment
30. Controlled comparison of tetracycline and furazolidone in cholera
31. Randomised double blind trial of single dose doxycycline for treating cholera in adults
32. Efficacy of a single dose of furazolidone for treatment of cholera in children
33. Effect of chemotherapy on the duration of diarrhoea, and on vibrio excretion by cholera patients
34. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera
35. Ciprofloxacin for the treatment of cholera: A randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults
36. World Health Organization: WHO expert committee on cholera. Second report
37. World Health Organization: Guidelines for cholera control. Programme for control of diarrhoeal diseases
38. Estudio de transmission familiar en pacientes con colera en Lima 1991
39. R-factors in Calcutta strains of Vibrio cholerae and members of the Enterobacteriaceae
40. Transmission of multiple drug-resistence from Shigella flexneri to Vibrio comma through conjugation
41. Efflux pumps and drug resistance in gram-negative bacteria
42. Proton-dependent multidrug efflux systems
43. Multidrug resistance pumps provide broad defense: MDR pumps expel a broad array of otherwise toxic molecules, including many antibiotics, from microorganisms
44. Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae
45. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia
46. Mobile gene cassettes and integrons: Capture and spread of genes by site-specific recombination
47. Gene cassettes: A new class of mobile element
48. Class 1 integrons, gene cassettes, mobility, and epidemiology
49. Cholera in Vietnam: Changes in genotypes and emergence of class 1 Integrons containing aminoglycoside resistance gene cassettes in Vibrio cholerae O1 strains isolated from 1979 to 1996
50. Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand
51. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O 139
52. Emergence of a unique O3:K6 clone of Vibrio parahaemolyticus in Calcutta, India, and isolation of strains from the same clonal group from Southeast Asian travelers arriving in Japan
53. Climate and infectious disease: Use of remote sensing for detection of Vibrio cholerae by indirect measurement
54. Temperature-induced recovery of Vibrio cholerae from the viable but nonculturable state: Growth or resuscitation?